MedPath

Metronidazole

Metronidazole Tablets, USP

Approved
Approval ID

f426cddc-8b70-c0a7-e053-2995a90a74e0

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Apr 9, 2025

Manufacturers
FDA

Redpharm Drug, inc.

DUNS: 828374897

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Metronidazole

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code67296-0078
Application NumberANDA070033
Product Classification
M
Marketing Category
C73584
G
Generic Name
Metronidazole
Product Specifications
Route of AdministrationORAL
Effective DateApril 9, 2025
FDA Product Classification

INGREDIENTS (5)

MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
CROSPOVIDONE (15 MPA.S AT 5%)Inactive
Code: 68401960MK
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
HYDROGENATED COTTONSEED OILInactive
Code: Z82Y2C65EA
Classification: IACT
METRONIDAZOLEActive
Quantity: 500 mg in 1 1
Code: 140QMO216E
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.